Zoetis has grown revenue 5.0% a year over three years and 5.1% a year over five, with earnings per share compounding at 8.5%. Revenue growth, 3-year annual rate: +5.0% (Drug Manufacturers - Specialty & Generic median +15%). Revenue growth, 5-year rate: +5.1%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +8.5%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 15, FY2011 to FY2025, as filed.

ZTSZoetis

HealthcareUSD

$77.53

$72.6352 weeks$154.88

Is it growing?

Is ZTS growing?

Zoetis has grown revenue 5.0% a year over three years and 5.1% a year over five, with earnings per share compounding at 8.5%.

+5.0%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +5.1%
Revenue growth, 5-year rate · +5.0% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +8.5%
Earnings per share, 3-year rate · revenue +5.0% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 15
Years of annual history on file · FY2011 to FY2025, as filed